Literature DB >> 11863123

Calcium-sensing receptor gene polymorphism affects the parathyroid response to moderate hypercalcemic suppression in patients with end-stage renal disease.

K Yokoyama1, T Shigematsu, T Tsukada, S Hara, A Yamada, Y Kawaguchi, T Hosoya.   

Abstract

AIM: The basic mechanism of secondary hyperparathyroidism is still unclear, but a change in Ca2+ sensing by parathyroid cells is possibly involved in this uremic complication. A rightward shift of the calcium set-point and an increase of the minimum secretion rate have been found in secondary hyperparathyroidism, indicating abnormal calcium sensing.
METHODS: We evaluated the effect of calcium sensing receptor (CaR) gene polymorphism (codon G990R) on the response of the parathyroid gland to moderate hypercalcemic suppression in 77 ESRD patients on regular hemodialysis (HD using 2.5 mEq/l Ca2+ dialysate). All patients underwent an HD session with 3.0 mEq/l Ca2+ dialysate to suppress parathyroid hormone (PTH). Then we investigated the effect of CaR gene polymorphism on the parathyroid response to hypercalcemic stimulation.
RESULTS: Patients were divided into 3 groups on the basis of genotype (GG = 33 patients (42.9%), GR = 39 patients (50.6%), RR = 5 patients (6.5%)). Baseline intact PTH levels in patients without the R allele were not significantly different from those in patients with the R allele (GG group, 181.4 +/- 31.1 pg/ml vs. GR and RR groups, 230 +/- 51.2 pg/ml: mean +/- SEM). The significant effect of moderate hypercalcemic suppression on the intact PTH level was observed in the GG group (p < 0.01) but not in the GR and RR groups, despite the identical increase in Ca2+.
CONCLUSION: Our results suggest that CaR gene polymorphism (codon G990R) influences the responsiveness of the parathyroid gland to changes of extracellular Ca2+ in ESRD patients. The glands of patients with the GG genotype of the CaR gene may be more sensitive to extracellular Ca2+ changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863123     DOI: 10.5414/cnp57131

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  Cinacalcet HCl therapy in East Asian patients and rs1042636 carriers.

Authors:  H M Rothe
Journal:  Clin Exp Nephrol       Date:  2018-02-06       Impact factor: 2.801

Review 2.  The calcium-sensing receptor and calcimimetics in blood pressure modulation.

Authors:  Sanela Smajilovic; Shozo Yano; Reza Jabbari; Jacob Tfelt-Hansen
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 3.  Physiology and pathophysiology of the calcium-sensing receptor in the kidney.

Authors:  Daniela Riccardi; Edward M Brown
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-18

4.  Associations of the calcium-sensing receptor gene CASR rs7652589 SNP with nephrolithiasis and secondary hyperparathyroidism in haemodialysis patients.

Authors:  Alicja E Grzegorzewska; Mateusz Paciorkowski; Adrianna Mostowska; Bartosz Frycz; Wojciech Warchoł; Ireneusz Stolarek; Marek Figlerowicz; Paweł P Jagodziński
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

5.  Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study.

Authors:  Alicja E Grzegorzewska; Bartosz A Frycz; Monika Świderska; Leszek Niepolski; Adrianna Mostowska; Paweł P Jagodziński
Journal:  BMC Nephrol       Date:  2019-11-27       Impact factor: 2.388

6.  Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.

Authors:  Sohyun Jeong; In-Wha Kim; Kook-Hwan Oh; Nayoung Han; Kwon Wook Joo; Hyo Jin Kim; Jung Mi Oh
Journal:  Drug Des Devel Ther       Date:  2016-07-08       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.